RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Ler esta página em: English · العربية · Français · Português
Register / Egypt / DEA-EG-2026-0079
Egyptian Drug Authority · Egypt
DEA-EG-2026-0079
Tier 1 · Regulator-publishedUnclassifiedAviso ao públicoStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
report no.(79) For 2026
Date issued
Sept 2026
Recorded by us
2026-09-10 17:14:57 UTC
Produto
Eltroxin50mcg
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Fabricante
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Números de lote
Not published with the notice
Prazos de validade
Not published with the notice
Action type
Aviso ao público
Classificação
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Not stated by the issuing authority
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Texto do aviso
Eltroxin 50mcg 22L008 DEC 2025 – DEC 2028 Aspen تداول عبوات مجهولة المصدر من الصنف المذكور وذلك بناءً على ما ورد الينا من VLD Healthcare الوكيل الحصري الرسمي لشركةAspen المالك الاصلي للمستحضر حيث افادت ان جميع العبوات بالبيانات الموضحة لا تخصها و لم يتم تصنيعها بمعرفتها, حيث يمكن تمييزالعبوات مجهولة المصدر كما هو موضح بالرابط ضبط وتحريز العبوات الغير مطابقة للمواصفات من المستحضر طبقا لما هو وارد بالرابط في حالة الشك في المستحضر الصيدلى يتم الرجوع الى هيئة الدواء المصرية سواء بالإتصال بالخط الساخن 15301او الموقع الإلكترونى الخاص بالهيئة. يمكن الضغط على الرابطللإطلاع على الصور الخاصة بالمستحضر المقلد. سبتمبر2026 منشور غش تجاري اسم المستحضر سبب التحذير الإجراءات التصحيحية نصائح للمستهلكين هذا التنبيه خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على تداول المستحضر بشكل عام رقم التشغيلة تاريخ الانتاج و الانتهاء الشركة المصنعة المدونة على العبوات
Estado
Em vigor
Superseded by
Not superseded. This is the current version.
Version
7

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
1a7a66ee837c462c6bcd95ca31ad13dba503af1bf2ec1c7b0ae69c0f24112b08
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-10 17:18:09 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0079: Eltroxin50mcg — Aviso ao público, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0079

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.